BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24458959)

  • 41. Use of nonsteroidal anti-inflammatory drugs to prevent heterotopic ossification after spinal cord injury: a retrospective chart review.
    Zakrasek EC; Yurkiewicz SM; Dirlikov B; Pence BT; Crew JD
    Spinal Cord; 2019 Mar; 57(3):214-220. PubMed ID: 30254206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pelvic MRI in spinal cord injury patients: incidence of muscle signal change and early heterotopic ossification.
    McKean D; Ather S; Gandhi A; Hubble T; Belci M; Tiberti S; Papanikitas J; Yanny S; King D; Hughes R; Meagher T; de Heredria LL
    Spinal Cord; 2021 Jun; 59(6):635-641. PubMed ID: 32873893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention and treatment of heterotopic ossification after spinal cord injury.
    Banovac K; Sherman AL; Estores IM; Banovac F
    J Spinal Cord Med; 2004; 27(4):376-82. PubMed ID: 15484668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation and management of heterotopic ossification in patients with spinal cord injury.
    Banovac K; Gonzalez F
    Spinal Cord; 1997 Mar; 35(3):158-62. PubMed ID: 9076866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle.
    Genêt F; Kulina I; Vaquette C; Torossian F; Millard S; Pettit AR; Sims NA; Anginot A; Guerton B; Winkler IG; Barbier V; Lataillade JJ; Le Bousse-Kerdilès MC; Hutmacher DW; Levesque JP
    J Pathol; 2015 Jun; 236(2):229-40. PubMed ID: 25712044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The sensitivity of ultrasound screening examination in detecting heterotopic ossification following spinal cord injury.
    Rosteius T; Suero EM; Grasmücke D; Aach M; Gisevius A; Ohlmeier M; Meindl R; Schildhauer TA; Citak M
    Spinal Cord; 2017 Jan; 55(1):71-73. PubMed ID: 27349610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin D deficiency in individuals with a spinal cord injury: a literature review.
    Flueck JL; Perret C
    Spinal Cord; 2017 May; 55(5):428-434. PubMed ID: 27824059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterotopic ossification in the hand of a patient with spinal cord injury.
    Lynch C; Pont A; Weingarden SI
    Arch Phys Med Rehabil; 1981 Jun; 62(6):291-3. PubMed ID: 6786254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Computerized quantitative radionuclide assessment of heterotopic ossification in spinal cord injury patients.
    Kim SW; Wu SY; Kim RC
    Paraplegia; 1992 Nov; 30(11):803-7. PubMed ID: 1484734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence and characteristics of heterotopic ossification after spinal cord injury: a single institution study in India.
    Rawat N; Chugh S; Zachariah K; Ghosh S
    Spinal Cord Ser Cases; 2019; 5():72. PubMed ID: 31632730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tibial tenderness identifies secondary hyperparathyroidism responding to high-dose vitamin D in Pakistani women.
    Ali B; Butt A; Fatima A; McDonnell ME; Masud F
    Endocr Pract; 2013; 19(4):596-601. PubMed ID: 23425639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterotopic ossification of the shoulder joint following spinal cord injury: an analysis of 21 cases after single-dose radiation therapy.
    Citak M; Grasmücke D; Cruciger O; Königshausen M; Meindl R; Schildhauer TA; Aach M
    Spinal Cord; 2016 Apr; 54(4):303-5. PubMed ID: 26503223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors Associated with Higher Rates of Heterotopic Ossification after Spinal Cord Injury: A Systematic Review and Meta-Analysis.
    Yolcu YU; Wahood W; Goyal A; Alvi MA; Reeves RK; Qu W; Gerberi DJ; Goncalves S; Bydon M
    Clin Neurol Neurosurg; 2020 Aug; 195():105821. PubMed ID: 32388145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The roles of serum alkaline and bone alkaline phosphatase levels in predicting heterotopic ossification following spinal cord injury.
    Citak M; Grasmücke D; Suero EM; Cruciger O; Meindl R; Schildhauer TA; Aach M
    Spinal Cord; 2016 May; 54(5):368-70. PubMed ID: 26643987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of etidronate on late development of heterotopic ossification after spinal cord injury.
    Banovac K
    J Spinal Cord Med; 2000; 23(1):40-4. PubMed ID: 10752873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of heterotopic ossification after spinal cord injury.
    Banovac K; Gonzalez F; Renfree KJ
    J Spinal Cord Med; 1997 Jan; 20(1):60-5. PubMed ID: 9097258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early diagnosis of heterotopic ossification among patients admitted to a neurological Post-Intensive Care Rehabilitation Unit.
    Carpentier VT; Salga M; Gatin L; Genêt F; Paquereau J
    Eur J Phys Rehabil Med; 2021 Aug; 57(4):527-534. PubMed ID: 33448758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathophysiology of heterotopic ossification.
    Zychowicz ME
    Orthop Nurs; 2013; 32(3):173-7; quiz 178-9. PubMed ID: 23695764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury.
    Estrores IM; Harrington A; Banovac K
    J Spinal Cord Med; 2004; 27(5):434-7. PubMed ID: 15648796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The predictive value of creatine phosphokinase and alkaline phosphatase in identification of heterotopic ossification in patients after spinal cord injury.
    Singh RS; Craig MC; Katholi CR; Jackson AB; Mountz JM
    Arch Phys Med Rehabil; 2003 Nov; 84(11):1584-8. PubMed ID: 14639555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.